Compile Data Set for Download or QSAR
Report error Found 606 for UniProtKB: P18084
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  21nMAssay Description:Binding affinity to human integrin alphaVbeta5 by after 2 hrs liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50464108(CHEMBL4241824)
Affinity DataKd:  21nMAssay Description:Binding affinity to human integrin alphaVbeta5 by after 2 hrs liquid scintillation countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50021393(CHEMBL3289604)
Affinity DataEC50:  5.10nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50021394(CHEMBL3289605)
Affinity DataEC50:  505nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50021395(CHEMBL3289606)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50550222(CHEMBL4777693)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50550223(CHEMBL4794300)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50550226(CHEMBL4782288)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50550224(CHEMBL4797755)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50550227(CHEMBL4755971)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50505781(CHEMBL4461668)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50550228(CHEMBL4743438)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50505772(CHEMBL4589062)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50505782(CHEMBL4586928)
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50550225(CHEMBL4764510)
Affinity DataEC50:  670nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50505779(CHEMBL4461771)
Affinity DataEC50:  376nMAssay Description:Agonist activity at alphaVbeta5 in human MCF7 cells assessed as increase in cell adhesion to fibrinogen pre-incubated for 30 mins before fibrinogen a...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279567((3S)-3-(3-bromo-5-chloro-phenyl)-3-[[2-[[5-[(5-hyd...)
Affinity DataIC50: 0.100nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279572((3S)-3-[3-bromo-5-fluoro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.100nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279573((3S)-3-(3,5-dibromophenyl)-3-[[2-[[5-[(5-hydroxy-1...)
Affinity DataIC50: 0.100nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50120519((7-{[4-(1,4,5,6-Tetrahydro-pyrimidin-2-ylamino)-bu...)
Affinity DataIC50: 0.100nMAssay Description:Displacement of vitronectin from human integrin alphaV-beta5More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279567((3S)-3-(3-bromo-5-chloro-phenyl)-3-[[2-[[5-[(5-hyd...)
Affinity DataIC50: 0.100nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279572((3S)-3-[3-bromo-5-fluoro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.100nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279573((3S)-3-(3,5-dibromophenyl)-3-[[2-[[5-[(5-hydroxy-1...)
Affinity DataIC50: 0.100nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50237601([5-Benzyl-11-(3-guanidino-propyl)-8-isopropyl-3,6,...)
Affinity DataIC50: 0.110nMAssay Description:Displacement of [125I]echistatin from AlphaV-beta-5 integrin receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50237601([5-Benzyl-11-(3-guanidino-propyl)-8-isopropyl-3,6,...)
Affinity DataIC50: 0.110nMAssay Description:Displacement of [125I]-echistatin from alpha-v-beta-5 integrin receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50237601([5-Benzyl-11-(3-guanidino-propyl)-8-isopropyl-3,6,...)
Affinity DataIC50: 0.110nMAssay Description:Displacement of [125I]Echistatin from human placental integrin alpha-V-beta-5 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50235980(CHEMBL429876 | EMD-121974 | cyclo(Arg-Gly-Asp-D-Ph...)
Affinity DataIC50: 0.130nMAssay Description:Displacement of [125I]echistatin from AlphaV-beta-5 integrin receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50235980(CHEMBL429876 | EMD-121974 | cyclo(Arg-Gly-Asp-D-Ph...)
Affinity DataIC50: 0.130nMAssay Description:Displacement of [125I]-echistatin from alpha-v-beta-5 integrin receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50235980(CHEMBL429876 | EMD-121974 | cyclo(Arg-Gly-Asp-D-Ph...)
Affinity DataIC50: 0.130nMAssay Description:Displacement of [125I]echistatin from human integrin alpha-V-beta-5 receptor by solid phase assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50235980(CHEMBL429876 | EMD-121974 | cyclo(Arg-Gly-Asp-D-Ph...)
Affinity DataIC50: 0.130nMAssay Description:Displacement of [125I]Echistatin from human placental integrin alpha-V-beta-5 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50308730(4-((2S,5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-...)
Affinity DataIC50: 0.170nMAssay Description:Displacement of [125I]echistatin from integrin alphaVbeta5 receptor after 3 hrs by gamma countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279560((3S)-3-(3,5-dibromophenyl)-3-(2-(3-hydroxy-5-((5-h...)
Affinity DataIC50: 0.200nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279562((3S)-3-[3-chloro-5-(difluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.200nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279565((3S)-3-[3-bromo-5-chloro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.200nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279566((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl]3-[[2-[...)
Affinity DataIC50: 0.200nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50120520((7-{[4-(4,5-Dihydro-1H-imidazol-2-ylamino)-butyryl...)
Affinity DataIC50: 0.200nMAssay Description:Displacement of vitronectin from human integrin alphaV-beta5More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279560((3S)-3-(3,5-dibromophenyl)-3-(2-(3-hydroxy-5-((5-h...)
Affinity DataIC50: 0.200nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279562((3S)-3-[3-chloro-5-(difluoromethyl)phenyl)-3-(2-(3...)
Affinity DataIC50: 0.200nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279565((3S)-3-[3-bromo-5-chloro-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.200nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279566((3S)-3-[3-chloro-5-(trifluoromethyl)phenyl]3-[[2-[...)
Affinity DataIC50: 0.200nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50166693(3-Pyridin-3-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8]na...)
Affinity DataIC50: 0.210nMAssay Description:Binding affinity to Integrin alpha-v-beta-5 receptor by ELISA assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279568((3S)-3-[3-bromo-5-(trifluoromethyl)phenyl]-3-[[2-[...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279570((3S)-3-[3-bromo-5-methyl-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279574((3S)-3-[3,5-dichloro-phenyl)-3-(2-(3-hydroxy-5-((5...)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:Recombinant human vitronectin (R&D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50120517({7-[(4-5,6,7,8-Tetrahydro-[1,8]naphthyridin-2-yl-b...)
Affinity DataIC50: 0.300nMAssay Description:Displacement of vitronectin from human integrin alphaV-beta5More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279568((3S)-3-[3-bromo-5-(trifluoromethyl)phenyl]-3-[[2-[...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279570((3S)-3-[3-bromo-5-methyl-phenyl)-3-(2-(3-hydroxy-5...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM279574((3S)-3-[3,5-dichloro-phenyl)-3-(2-(3-hydroxy-5-((5...)
Affinity DataIC50: 0.300nMAssay Description:Recombinant human vitronectin (R& D Systems, 2308-VN) at 0.25 μg/mL in TBS+ buffer (25 mM Tris pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1 mM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50308728(1-(4-((5S,11S,14R)-14-benzyl-11-(carboxymethyl)-5-...)
Affinity DataIC50: 0.350nMAssay Description:Displacement of [125I]echistatin from integrin alphaVbeta5 receptor after 3 hrs by gamma countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetIntegrin alpha-V/beta-5(Human)
University of Strathclyde

Curated by ChEMBL
LigandPNGBDBM50308726(2-[(2S,5R,8S,11S)-5-benzyl-11-(3-carbamimidamidopr...)
Affinity DataIC50: 0.370nMAssay Description:Displacement of [125I]echistatin from integrin alphaVbeta5 receptor after 3 hrs by gamma countingMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 606 total ) | Next | Last >>
Jump to: